Subtype
Tenosynovial Giant Cell Tumor
CI-CAN-00001563TGCTExplore in graph →
Non-malignant9 active trials
- NCIt
- C3402
- DOID
- 314
- MeSH
- D000070779
Loading cancer entity…
Subtype
CI-CAN-00001563TGCTExplore in graph →
Clinical trials
25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02471716 | Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor(FPA008-002) | completed | Phase 1 / Phase 2 | 66 | Five Prime Therapeutics, Inc.INDUSTRY | 6 | Aug 31, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Aug 31, 2021source: clinicaltrials